Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is angiotensin-converting-enzyme inhibition renoprotective in young patients with IgA nephropathy?

Nature Clinical Practice Nephrology volume 3, pages 594–595 (2007)Cite this article

boxed-textCoppo R et al. (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18: 1880–1888

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Li PK et al. (2002) Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives. Nephrol Dial Transplant 17: 64–69

    Article  CAS  Google Scholar 

  2. Barratt J and Feehally J (2006) Treatment of IgA nephropathy. Kidney Int 69: 1934–1938

    Article  CAS  Google Scholar 

  3. Praga M et al. (2003) Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 14: 1578–1583

    Article  CAS  Google Scholar 

  4. Li PK et al. (2006) Hong Kong study using valsartan in IgA nephropathy (HKVIN)—a double-blind, randomized, placebo-controlled study. Am J Kidney Dis 47: 751–760

    Article  CAS  Google Scholar 

  5. MacKinnon M et al. (2006) Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 48: 8–20

    Article  CAS  Google Scholar 

  6. Pozzi C et al. (2006) ACE inhibitors and angiotensin II receptor blockers in IgA nephropathy with mild proteinuria: the ACEARB study. J Nephrol 19: 508–514

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Prince of Wales Hospital, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong philipli@cuhk.edu.hk

Authors and Affiliations

  1. PKT Li is Chief of Nephrology and Honorary Professor of Medicine at the Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong.,

    Philip KT Li

Authors
  1. Philip KT Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, P. Is angiotensin-converting-enzyme inhibition renoprotective in young patients with IgA nephropathy?. Nat Rev Nephrol 3, 594–595 (2007). https://doi.org/10.1038/ncpneph0611

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0611

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing